Calmy, A., Tovar Sanchez, T., Kouanfack, C., Mpoudi-Etame, M., Leroy, S., Perrineau, S., Lantche Wandji, M., Tetsa Tata, D., Omgba Bassega, P., Abong Bwenda, T., Varloteaux, M., Tongo, M., Mpoudi-Ngolé, E., Montoyo, A., Mercier, N., LeMoing, V., Peeters, M., Reynes, J., Delaporte, E., , , Calmy, A., Tovar Sanchez, T., Kouanfack, C., Mpoudi-Etame, M., Leroy, S., Perrineau, S., Lantche-Wandji, M., Tetsa-Tata, D., Omgba-Bassega, P., Abong-Bwenda, T., Varloteaux, M., Tongo, M., Mpoudi-Ngolé, E., Montoyo, A., Mercier, N., LeMoing, V., Peeters, M., Reynes, J., Delaporte, E., Ayouba, A., Agholeng, A., Butel, C., Cournil, A., Eymard-Duvernay, S., Granouillac, B., Izard, S., Lacroix, A., Serrano, L., Vidal, N., Fouda, P., Mougnoutou, R., Olinga, J., Omgba, V., Tchokonte-Ngandé, S., Ymele, B., Epoupa-Mpacko, C., Fotso, M., Moukoko, R., Nké, T., Akamba, A., Lekelem, S., Tongo-Fotack, S., Ngono, S., Tanga, M., Ebong, E., Edoul-Mbesse, G., Tongo, M., Ciaffi, L., Koulla-Shiro, S., Manirakiza, G., Mimbé, E., Boyer, S., Bousmah, M., Maradan, G., Nishimwe, M., Spire, B., Lê, M., Peytavin, G., Diallo, A., Fournier, I., Rekacewicz, C., & Perez Casas, C. (2020). dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon. Lancet, 7(10), e677–e687. http://access.bl.uk/ark:/81055/vdc_100110822313.0x000005